{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T12:13:41Z","timestamp":1767183221607},"reference-count":154,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1097\/grf.0b013e31824b4629","type":"journal-article","created":{"date-parts":[[2012,2,18]],"date-time":"2012-02-18T03:09:28Z","timestamp":1329534568000},"page":"75-95","source":"Crossref","is-referenced-by-count":16,"title":["Surgical Management of Epithelial Ovarian Cancer"],"prefix":"10.1097","volume":"55","author":[{"given":"RITU","family":"SALANI","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"ROBERT E.","family":"BRISTOW","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-9-20210126","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics.","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"R2-9-20210126","doi-asserted-by":"crossref","first-page":"277","DOI":"10.3322\/caac.20073","article-title":"Cancer statistics, 2010.","volume":"60","author":"Jemal","year":"2010","journal-title":"CA Cancer J Clin"},{"key":"R4-9-20210126","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1093\/jnci\/djm199","article-title":"Discrimination between benign and malignant adnexal masses by specialist ultrasound examination versus serum CA-125.","volume":"99","author":"Van Calster","year":"2007","journal-title":"J Natl Cancer Inst"},{"key":"R6-9-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/01.AOG.0000149159.69560.ef","article-title":"Validation of referral guidelines for women with pelvic masses.","volume":"105","author":"Im","year":"2005","journal-title":"Obstet Gynecol"},{"key":"R7-9-20210126","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/j.1471-0528.1990.tb02448.x","article-title":"A risk of malignancy index incorporating CA125, ultrasound and menopausal status for the accurate preoperative diagnosis of ovarian cancer.","volume":"97","author":"Jacobs","year":"1990","journal-title":"Br J Obstet Gynecol"},{"key":"R8-9-20210126","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.ygyno.2009.11.014","article-title":"Evaluation of the risk of malignancy index in daily clinical management of adnexal masses.","volume":"116","author":"van den Akker","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R9-9-20210126","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ygyno.2007.10.017","article-title":"The use of multiple novel tumor biomarkers for the detection of ovarian carcinoma in patients with a pelvic mass.","volume":"108","author":"Moore","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R11-9-20210126","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/AOG.0b013e318224fce2","article-title":"Evaluation of the diagnostic accuracy of the risk of ovarian malignancy algorithm in women with a pelvic mass.","volume":"118","author":"Moore","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1097\/AOG.0b013e31821b5118","article-title":"Effectiveness of a multivariate index assay in the preoperative assessment of ovarian tumors.","volume":"117","author":"Ueland","year":"2011","journal-title":"Obstet Gynecol"},{"key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/1098-2388(200007\/08)19:1<36::AID-SSU6>3.0.CO;2-E","article-title":"Surgical staging of early invasive epithelial ovarian tumors.","volume":"19","author":"Leblanc","year":"2000","journal-title":"Semin Surg Oncol"},{"key":"R14-9-20210126","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jnci\/djj019","article-title":"Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.","volume":"98","author":"Earle","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"R15-9-20210126","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/cncr.21616","article-title":"Surgery by consultant gynecologic oncologists improves survival in patients with ovarian carcinoma.","volume":"106","author":"Engelen","year":"2006","journal-title":"Cancer"},{"key":"R16-9-20210126","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.ygyno.2009.12.033","article-title":"Quality of care in advanced ovarian cancer: the importance of provider specialty.","volume":"117","author":"Mercado","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.ygyno.2005.07.121","article-title":"The results of treatment of epithelial ovarian cancer after centralisation of primary surgery. Results from North Jutland, Denmark.","volume":"99","author":"Soegaard Andersen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R19-9-20210126","first-page":"499","article-title":"The effect of centralization of primary surgery on survival in ovarian cancer patients.","volume":"102","author":"Tingulstad","year":"2003","journal-title":"Obstet Gynecol"},{"key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.ygyno.2010.05.025","article-title":"The National Cancer Database report on advanced-stage epithelial ovarian cancer: impact of hospital surgical case volume on overall survival and surgical treatment paradigm.","volume":"118","author":"Bristow","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R21-9-20210126","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.ejca.2009.12.012","article-title":"Understanding the problem of inadequately staging early ovarian cancer.","volume":"46","author":"Timmers","year":"2010","journal-title":"Eur J Cancer"},{"key":"R22-9-20210126","doi-asserted-by":"crossref","first-page":"3072","DOI":"10.1001\/jama.1983.03340220040030","article-title":"Staging laparotomy and ovarian cancer.","volume":"250","author":"Young","year":"1983","journal-title":"JAMA"},{"key":"R23-9-20210126","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/1477-7819-8-106","article-title":"Lymph node metastasis in grossly apparent clinical stage Ia epithelial ovarian cancer: Hacettepe experience and review of literature.","volume":"8","author":"Desteli","year":"2010","journal-title":"World J Surg Oncol"},{"key":"R24-9-20210126","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1093\/jnci\/95.2.113","article-title":"Impact of adjuvant chemotherapy and surgical staging in early stage ovarian carcinoma: European Organisation for Research and Treatment of Canceradjuvant chemotherapy in ovarian neoplasm trial.","volume":"95","author":"Trimbos","year":"2003","journal-title":"J Natl Cancer Inst"},{"key":"R25-9-20210126","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1111\/IGC.0b013e3181ef8e03","article-title":"Lymph node sampling and taking of blind biopsies are important elements of the surgical staging of early ovarian cancer.","volume":"20","author":"Timmers","year":"2010","journal-title":"Int J Gyn Cancer"},{"key":"R26-9-20210126","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ygyno.2010.12.359","article-title":"Surgical staging of early stage epithelial ovarian cancer: results from the CDC-NPCR ovarian patterns of care study.","volume":"121","author":"Cress","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R27-9-20210126","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1006\/gyno.2000.6027","article-title":"Pattern of lymph node metastases in clinically unilateral stage I invasive epithelial ovarian carcinomas.","volume":"80","author":"Cass","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R28-9-20210126","first-page":"101","article-title":"Surgical resection of tumor bulk in the primary treatment of ovarian carcinoma.","volume":"42","author":"Griffiths","year":"1975","journal-title":"Natl Cancer Inst Monogr"},{"key":"R29-9-20210126","first-page":"235","article-title":"Role of cytoreductive surgical treatment in the management of advanced ovarian cancer.","volume":"63","author":"Griffiths","year":"1979","journal-title":"Cancer Treat Rep"},{"key":"R31-9-20210126","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/S0002-9378(94)70090-7","article-title":"The effect of diameter of largest residual disease on survival after primary cytoreductive surgery in patients with suboptimal residual epithelial ovarian carcinoma.","volume":"170","author":"Hoskins","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"R33-9-20210126","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1200\/JCO.2002.20.5.1248","article-title":"Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis.","volume":"20","author":"Bristow","year":"2002","journal-title":"J Clin Oncol"},{"key":"R34-9-20210126","first-page":"879","article-title":"Modified posterior exenteration for ovarian cancer.","volume":"78","author":"Eisenkop","year":"1991","journal-title":"Obstet Gynecol"},{"key":"R35-9-20210126","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ajog.2005.03.046","article-title":"Sites of bowel resected to achieve optimal ovarian cancer cytoreduction: implications regarding surgical management.","volume":"193","author":"Hoffman","year":"2005","journal-title":"Am J Obstet Gyencol"},{"key":"R36-9-20210126","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.ygyno.2009.05.004","article-title":"Secondary cytoreductive surgery including rectosigmoid colectomy for recurrent ovarian cancer: operative technique and clinical outcome.","volume":"114","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R37-9-20210126","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.ejogrb.2011.01.003","article-title":"Comparison of the efficacy of low anterior resection with primary anastomosis and Hartmanns procedure in advanced primary or recurrent epithelial ovarian cancer.","volume":"156","author":"Kim","year":"2011","journal-title":"Eur J Obstet Gynecol and Reprod Biol"},{"key":"R38-9-20210126","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.ajog.2006.03.079","article-title":"Colorectal resection in patients with ovarian and primary peritoneal carcinoma.","volume":"195","author":"Tebes","year":"2006","journal-title":"Am J Obstet Gynecol"},{"key":"R39-9-20210126","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.ygyno.2005.07.112","article-title":"Morbidity of rectosigmoid resection and primary anastomosis in patients undergoing primary cytoreductive surgery for advanced epithelial ovarian cancer.","volume":"99","author":"Mourton","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R40-9-20210126","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1200\/JCO.2007.11.0932","article-title":"Role of surgery in ovarian carcinoma.","volume":"25","author":"Fader","year":"2007","journal-title":"J Clin Oncol"},{"key":"R41-9-20210126","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.ygyno.2009.04.009","article-title":"Total colectomy as part of primary cytoreductive surgery in advanced Mullerian cancer.","volume":"114","author":"Song","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R42-9-20210126","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2008.02.020","article-title":"Transverse colectomy in ovarian cancer surgical cytoreduction: operative technique and clinical outcome.","volume":"109","author":"Bristow","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R43-9-20210126","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ygyno.2009.05.037","article-title":"Extended left colon resections as part of complete cytoreduction for ovarian cancer: tips and considerations.","volume":"114","author":"Silver","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R44-9-20210126","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.ygyno.2007.08.003","article-title":"Survival impact of multiple bowel resections in patients undergoing primary cytoreductive surgery for advanced ovarian cancer: a case-control study.","volume":"107","author":"Salani","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R45-9-20210126","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.jamcollsurg.2006.06.019","article-title":"Bowel resection at the time of primary debulking for epithelial ovarian carcinoma: outcomes in patients treated with platinum and taxane-based chemotherapy.","volume":"203","author":"Estes","year":"2006","journal-title":"J Am Coll Surg"},{"key":"R46-9-20210126","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1072-7515(03)00478-2","article-title":"Radical oophorectomy with primary stapled colorectal anastomosis for resection of locally advanced epithelial ovarian cancer.","volume":"197","author":"Bristow","year":"2003","journal-title":"J Am Coll Surg"},{"key":"R47-9-20210126","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ygyno.2011.04.041","article-title":"The impact of disease distribution on survival in patients with stage III epithelial ovarian cancer cytoreduced to microscopic residual: a Gynecologic Oncology Group study.","volume":"122","author":"Hamilton","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R48-9-20210126","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2009.11.022","article-title":"The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum.","volume":"116","author":"Zivanovic","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R49-9-20210126","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer.","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R50-9-20210126","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1016\/j.ygyno.2008.07.053","article-title":"Upper abdominal surgical procedures: liver mobilization and diaphragm peritonectomyresection, splenectomy, and distal pancreatectomy.","volume":"111","author":"Kehoe","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R51-9-20210126","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ygyno.2009.03.018","article-title":"Improved progression-free and overall survival in advanced ovarian cancer as a result of a change in surgical paradigm.","volume":"114","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R52-9-20210126","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ygyno.2007.10.001","article-title":"The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.","volume":"108","author":"Zivanovic","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R53-9-20210126","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/j.ygyno.2004.01.029","article-title":"Improved optimal cytoreduction rates for stages IIIC and IV epithelial ovarian, fallopian tube, and primary peritoneal cancer: a change in surgical approach.","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R55-9-20210126","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00404-010-1750-4","article-title":"Hepatic resection as part of secondary cytoreductive surgery for recurrent ovarian cancer involving the liver.","volume":"284","author":"Roh","year":"2011","journal-title":"Arch Gynecol Oncol"},{"key":"R56-9-20210126","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/S0090-8258(03)00004-0","article-title":"Hepatic resection for metachronous metastases from ovarian carcinoma.","volume":"89","author":"Merideth","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R57-9-20210126","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.amjsurg.2007.12.012","article-title":"Hepatic resection for recurrent metastatic ovarian cancer.","volume":"195","author":"Abood","year":"2008","journal-title":"Am J Surg"},{"key":"R58-9-20210126","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2008.09.046","article-title":"The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer.","volume":"112","author":"Lim","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R59-9-20210126","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ygyno.2010.12.328","article-title":"Celiac lymph node resection and porta hepatis disease resection in advanced or recurrent epithelial ovarian, fallopian tube, and primary peritoneal cancer.","volume":"121","author":"Martinez","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R60-9-20210126","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ygyno.2010.12.350","article-title":"Extended cytoreduction of tumor at the porta hepatis by an interdisciplinary team approach in patients with epithelial ovarian cancer.","volume":"121","author":"Song","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R61-9-20210126","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1245\/s10434-006-9048-2","article-title":"Splenectomy during secondary cytoreduction for ovarian cancer disease recurrence: surgical and survival data.","volume":"13","author":"Manci","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R62-9-20210126","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.2000.5800","article-title":"Splenectomy and surgical cytoreduction for ovarian cancer.","volume":"77","author":"Chen","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R63-9-20210126","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","article-title":"Splenectomy as part of cytoreductive surgery in ovarian cancer.","volume":"102","author":"Magtibay","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R64-9-20210126","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ygyno.2005.08.036","article-title":"Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer.","volume":"100","author":"Eisenkop","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R65-9-20210126","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1245\/s10434-011-1661-z","article-title":"Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer.","volume":"18","author":"McCann","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R66-9-20210126","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.ygyno.2008.10.011","article-title":"Incidence and management of pancreatic leaks after splenectomy with distal pancreatectomy performed during primary cytoreductive surgery for advanced ovarian, peritoneal and fallopian tube cancer.","volume":"112","author":"Kehoe","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R67-9-20210126","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/IGC.0b013e3181a3a833","article-title":"Characteristics and management of diaphragm involvement in patients with primary advanced-stage ovarian, fallopian tube, or peritoneal cancer.","volume":"19","author":"Einenkel","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R68-9-20210126","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ejca.2010.08.020","article-title":"Comparison of diaphragmatic surgery at primary or interval debulking in advanced ovarian carcinoma: an analysis of 163 patients.","volume":"47","author":"Tsolakidis","year":"2011","journal-title":"Euro J Cancer"},{"key":"R69-9-20210126","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ejso.2010.10.004","article-title":"Morbidity of diaphragmatic surgery for advanced ovarian cancer: retrospective study of 148 cases.","volume":"37","author":"Chereau","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"R70-9-20210126","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.ygyno.2010.07.017","article-title":"Surgical technique of diaphragm full-thickness resection and trans-diaphragmatic decompression of pneumothorax during cytoreductive surgery for ovarian cancer.","volume":"119","author":"Bashir","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R71-9-20210126","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.ygyno.2006.05.023","article-title":"Incidence and management of pleural effusions after diaphragm peritonectomy or resection for advanced Mullerian cancer.","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R72-9-20210126","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ygyno.2008.02.012","article-title":"Assessment of outcomes and morbidity following diaphragmatic peritonectomy for women with ovarian carcinoma.","volume":"109","author":"Dowdy","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R73-9-20210126","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ygyno.2005.08.027","article-title":"Surgical treatment of diaphragm disease correlates with improved survival in optimally debulked advanced stage ovarian cancer.","volume":"100","author":"Aletti","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R74-9-20210126","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1525-1438.2007.01006.x","article-title":"Role of diaphragmatic surgery in 69 patients with ovarian carcinoma.","volume":"18","author":"Devodler","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R75-9-20210126","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/j.ygyno.2004.04.032","article-title":"Diaphragm resection for ovarian cancer: technique and short-term complications.","volume":"94","author":"Cliby","year":"2004","journal-title":"Gynecol Oncol"},{"issue":"S1","key":"R76-9-20210126","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1111\/IGC.0b013e3181cff38b","article-title":"Predicting the outcome of cytoreductive surgery for advanced ovarian cancer: a review.","volume":"20","author":"Ibeanu","year":"2010","journal-title":"Int J Gyn Cancer"},{"key":"R77-9-20210126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1136\/ijgc-00009577-200401000-00005","article-title":"Preoperative predictors of suboptimal primary surgical cytoreduction in women with clinical evidence of advanced primary epithelial ovarian cancer.","volume":"14","author":"Brockbank","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"R78-9-20210126","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1006\/gyno.2000.5749","article-title":"The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma.","volume":"77","author":"Chi","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R79-9-20210126","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ygyno.2008.10.010","article-title":"A contemporary analysis of the ability of preoperative serum CA-125 to predict primary cytoreductive outcome in patients with advanced ovarian, tubal and peritoneal carcinoma.","volume":"112","author":"Chi","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R80-9-20210126","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1200\/JCO.1993.11.1.166","article-title":"Preoperative abdominopelvic computed tomographic prediction of optimal cytoreduction in epithelial ovarian carcinoma.","volume":"11","author":"Nelson","year":"1993","journal-title":"J Clin Oncol"},{"key":"R81-9-20210126","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1200\/JCO.2006.07.7800","article-title":"Multi-institutional reciprocal validation study of computed tomography predictors of suboptimal primary cytoreduction in patients with advanced ovarian cancer.","volume":"25","author":"Axtell","year":"2007","journal-title":"J Clin Oncol"},{"key":"R82-9-20210126","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.ygyno.2007.11.004","article-title":"Limited utility of conventional criteria for predicting unresectable disease in patients with advanced stage epithelial ovarian cancer.","volume":"108","author":"Salani","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R83-9-20210126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cncr.20376","article-title":"The utility of computed tomography scans in predicting suboptimal cytoreductive surgery in women with advanced ovarian carcinoma.","volume":"101","author":"Dowdy","year":"2004","journal-title":"Cancer"},{"key":"R84-9-20210126","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ygyno.2004.06.054","article-title":"Role of CT and MR imaging in predicting optimal cytoreduction of newly diagnosed primary epithelial ovarian cancer.","volume":"96","author":"Qayyum","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R85-9-20210126","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2007.11.002","article-title":"Prediction of suboptimal primary cytoreduction in primary ovarian cancer with combined positron emission tomographycomputed tomographya prospective study.","volume":"108","author":"Risum","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R86-9-20210126","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/j.ejso.2010.09.008","article-title":"Can complete tumor resection be predicted in advanced primary epithelial ovarian cancer A systematic evaluation of 360 consecutive patients.","volume":"36","author":"Fotopoulou","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"R87-9-20210126","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1016\/j.ejrad.2010.07.013","article-title":"FDG-PETCT in advanced ovarian cancer staging: value and pitfalls in detecting lesions in different abdominal and pelvic quadrants compared with laparoscopy.","volume":"80","author":"De Iaco","year":"2011","journal-title":"Eur J Radiol"},{"key":"R88-9-20210126","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0959-8049(11)70152-6","article-title":"Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.","volume":"47","author":"Vergote","year":"2011","journal-title":"Eur J Cancer"},{"key":"R89-9-20210126","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1006\/gyno.1996.4396","article-title":"Effect of surgical debulking on survival in stage IV ovarian cancer.","volume":"64","author":"Liu","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R90-9-20210126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1006\/gyno.1996.4550","article-title":"Stage IV ovarian cancer: impact of surgical debulking.","volume":"64","author":"Curtin","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R91-9-20210126","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1006\/gyno.1996.4540","article-title":"Prognostic significance of residual disease in patients with stage IV epithelial ovarian cancer.","volume":"64","author":"Munkarah","year":"1997","journal-title":"Gynecol Oncol"},{"key":"R92-9-20210126","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1002\/cncr.20920","article-title":"The clinical significance of malignant pleural effusions in patients with optimally debulked ovarian carcinoma.","volume":"103","author":"Eitan","year":"2005","journal-title":"Cancer"},{"key":"R93-9-20210126","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study.","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"key":"R94-9-20210126","first-page":"449","article-title":"Cytoreductive surgery for stage IV epithelial ovarian cancer.","volume":"18","author":"Zang","year":"1999","journal-title":"J Exp Clin Cancer Res"},{"key":"R95-9-20210126","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ygyno.2006.10.055","article-title":"Analysis of factors impacting operability in stage IV ovarian cancer: rationale use of a triage system.","volume":"105","author":"Aletti","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R96-9-20210126","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ygyno.2004.04.027","article-title":"The benefit of video-assisted thoracoscopic surgery before planned abdominal exploration in patients with suspected advanced ovarian cancer and moderate to large pleural effusions.","volume":"94","author":"Chi","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R97-9-20210126","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1111\/IGC.0b013e3181a84595","article-title":"Role of video-assisted thoracoscopy in patients with ovarian cancer and pleural effusion.","volume":"19","author":"Cohen-Mouly","year":"2009","journal-title":"Int J Gynecol Cancer"},{"key":"R98-9-20210126","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.ygyno.2006.10.010","article-title":"The impact of video-assisted thoracic surgery (VATS) in patients with suspected advanced ovarian malignancies and pleural effusions.","volume":"104","author":"Juretzka","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R99-9-20210126","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ygyno.2009.09.047","article-title":"Video-assisted thoracic surgery (VATS) evaluation of pleural effusions in patients with newly diagnosed advanced ovarian carcinoma can influence the primary management choice for these patients.","volume":"116","author":"Diaz","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R100-9-20210126","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1006\/gyno.2001.6526","article-title":"Thoracoscopy for the management of advanced epithelial ovarian cancer: a preliminary report.","volume":"84","author":"Eisenkop","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R101-9-20210126","first-page":"413","article-title":"Primary cytoreductive surgery for epithelial ovarian cancer.","volume":"61","author":"Hacker","year":"1983","journal-title":"Obstet Gynecol"},{"key":"R102-9-20210126","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0090-8258(92)90100-W","article-title":"The influence of cytoreductive surgery on recurrence-free interval and survival in small-volume stage III epithelial ovarian cancer: a Gynecologic Oncology Group study.","volume":"47","author":"Hoskins","year":"1992","journal-title":"Gynecol Oncol"},{"key":"R103-9-20210126","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJM199503093321002","article-title":"The effect of debulking surgery after induction chemotherapy on the prognosis in advanced epithelial ovarian cancer. Gynecological Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer.","volume":"332","author":"Van der Burg","year":"1995","journal-title":"N Engl J Med"},{"key":"R104-9-20210126","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.ygyno.2006.11.002","article-title":"Delaying the primary surgical effort for advanced ovarian cancer: a systematic review of neoadjuvant chemotherapy and interval cytoreduction.","volume":"104","author":"Bristow","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R105-9-20210126","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1056\/NEJMoa0908806","article-title":"Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer.","volume":"363","author":"Vergote","year":"2010","journal-title":"N Engl J Med"},{"key":"R106-9-20210126","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1056\/NEJMoa041125","article-title":"Secondary surgical cytoreduction for advanced ovarian carcinoma.","volume":"351","author":"Rose","year":"2004","journal-title":"N Engl J Med"},{"key":"R107-9-20210126","first-page":"CD006014","article-title":"Interval debulking surgery for advanced epithelial ovarian cancer.","volume":"10","author":"Tangjitgamol","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"R108-9-20210126","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ejca.2008.09.031","article-title":"EORTC-GCG process quality indicators for ovarian cancer surgery.","volume":"45","author":"Verleye","year":"2009","journal-title":"Eur J Cancer"},{"key":"R109-9-20210126","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1111\/j.1525-1438.2005.00135.x","article-title":"Port-site metastases after open laparoscopy: a study in 173 patients with advanced ovarian carcinoma.","volume":"15","author":"Vergote","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"R110-9-20210126","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3109\/13645706.2011.556648","article-title":"Laparoscopic second look operation for ovarian cancer: single center experiences.","volume":"20","author":"Hong","year":"2011","journal-title":"Minim Invasive Ther Allied Technol"},{"key":"R111-9-20210126","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s11864-011-0155-3","article-title":"Role of minimally invasive surgery in staging of ovarian cancer.","volume":"12","author":"Iglesias","year":"2011","journal-title":"Curr Treat Options Oncol"},{"key":"R112-9-20210126","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.ajog.2004.11.018","article-title":"The safety and efficacy of laparoscopic surgical staging of apparent stage I ovarian and fallopian tube cancers.","volume":"192","author":"Chi","year":"2005","journal-title":"Am J Obstet Gynecol"},{"key":"R113-9-20210126","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1525-1438.2008.01190.x","article-title":"Laparoscopic and laparotomic staging in stage I epithelial ovarian cancer: a comparison of feasibility and safety.","volume":"18","author":"Park","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R114-9-20210126","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/01.gco.0000233935.51801.48","article-title":"Laparoscopic staging of early ovarian carcinoma.","volume":"18","author":"Leblanc","year":"2006","journal-title":"Curr Opin Obstet Gynecol"},{"key":"R115-9-20210126","doi-asserted-by":"crossref","first-page":"126","DOI":"10.6004\/jnccn.2011.0011","article-title":"Indications for minimally invasive surgery for ovarian cancer.","volume":"9","author":"Han","year":"2011","journal-title":"J Natl Compr Canc Netw"},{"key":"R116-9-20210126","doi-asserted-by":"crossref","first-page":"155","DOI":"10.4293\/108680810X12785289143990","article-title":"The safety and efficacy of laparoscopic surgical staging and debulking of apparent advanced stage ovarian, fallopian tube, and primary peritoneal cancers.","volume":"14","author":"Nezhat","year":"2010","journal-title":"JSLS"},{"key":"R117-9-20210126","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.ygyno.2010.11.045","article-title":"Robotic approach for ovarian cancer: perioperative and survival results and comparison with laparoscopy and laparotomy.","volume":"121","author":"Magrina","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R118-9-20210126","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/j.ygyno.2010.09.007","article-title":"Robotic-assisted resection of liver and diaphragm recurrent ovarian carcinoma: description of technique.","volume":"120","author":"Holloway","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R119-9-20210126","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1159\/000159266","article-title":"A treatment selection protocol for recurrent ovarian cancer patients: the role of FDG-PETCT and staging laparoscopy.","volume":"75","author":"Fagotti","year":"2008","journal-title":"Oncology"},{"key":"R120-9-20210126","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/cncr.22447","article-title":"Secondary cytoreductive surgery for localized, recurrent epithelial ovarian cancer: analysis of prognostic factors and survival outcome.","volume":"109","author":"Salani","year":"2007","journal-title":"Cancer"},{"key":"R121-9-20210126","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.21845","article-title":"Guidelines and selection criteria for secondary cytoreductive surgery in patients with recurrent, platinum-sensitive epithelial ovarian carcinoma.","volume":"106","author":"Chi","year":"2006","journal-title":"Cancer"},{"key":"R122-9-20210126","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1245\/s10434-006-9273-8","article-title":"Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer.","volume":"14","author":"Benedetti-Panici","year":"2006","journal-title":"Ann Surg Oncol"},{"issue":"S3","key":"R123-9-20210126","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/j.1525-1438.2005.00430.x","article-title":"The role of surgery in recurrent ovarian cancer.","volume":"15","author":"Pfister","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"R124-9-20210126","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ygyno.2010.10.008","article-title":"Surgical management of recurrent ovarian cancer: the advantage of collaborative surgical management and a multidisciplinary approach.","volume":"120","author":"Burton","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R125-9-20210126","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1097\/IGC.0b013e31821743f9","article-title":"Preoperative factors predicting survival after secondary cytoreduction for recurrent ovarian cancer.","volume":"21","author":"Frederick","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R126-9-20210126","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1245\/s10434-006-9058-0","article-title":"Surgery in recurrent ovarian cancer: the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR trial.","volume":"13","author":"Harter","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"R127-9-20210126","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ygyno.2008.08.033","article-title":"Cytoreductive surgery for recurrent ovarian cancer: a meta-analysis.","volume":"112","author":"Bristow","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R128-9-20210126","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1097\/IGC.0b013e31820aaafd","article-title":"Prospective validation study of a predictive score for operability of recurrent ovarian cancer: the Multicenter Intergroup Study DESKTOP II. A project of the AGO Kommission OVAR, AGO Study Group, NOGGO, AGO-Austria, and MITO.","volume":"21","author":"Harter","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"R129-9-20210126","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2010.01.046","article-title":"Tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer: an updated series.","volume":"117","author":"Shih","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R130-9-20210126","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1245\/s10434-010-1245-3","article-title":"Clinical outcome of tertiary surgical cytoreduction in patients with recurrent epithelial ovarian cancer.","volume":"18","author":"Fotopoulou","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"R131-9-20210126","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ygyno.2004.07.033","article-title":"Tertiary cytoreduction in patients with recurrent ovarian carcinoma.","volume":"95","author":"Leitao","year":"2004","journal-title":"Gynecol Oncol"},{"key":"R132-9-20210126","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.ygyno.2006.08.037","article-title":"Tertiary cytoreductive surgery in recurrent ovarian cancer: selection criteria and survival outcome.","volume":"104","author":"Karam","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R133-9-20210126","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ygyno.2009.10.047","article-title":"Beyond tertiary cytoreduction in patients with recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer.","volume":"116","author":"Shih","year":"2010","journal-title":"Gynecol Oncol"},{"key":"R134-9-20210126","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0090-8258(03)00073-8","article-title":"Palliative surgery for bowel obstruction in recurrent ovarian cancer: an updated series.","volume":"89","author":"Pothuri","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R135-9-20210126","first-page":"CD002764","article-title":"Surgery for the resolution of symptoms in malignant bowel obstruction in advanced gynaecological and gastrointestinal cancer.","volume":"4","author":"Feuer","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"R136-9-20210126","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1634\/theoncologist.2009-0057","article-title":"A prospective outcomes analysis of palliative procedures performed for malignant intestinal obstruction due to recurrent ovarian cancer.","volume":"14","author":"Chi","year":"2009","journal-title":"Oncologist"},{"key":"R137-9-20210126","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ygyno.2004.09.058","article-title":"Percutaneous endoscopic gastrostomy tube placement in patients with malignant bowel obstruction due to ovarian carcinoma.","volume":"96","author":"Pothuri","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R138-9-20210126","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.ygyno.2007.11.035","article-title":"Colorectal stents for palliation of large bowel obstruction in recurrent gynecologic cancer: an updated series.","volume":"108","author":"Caceres","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R139-9-20210126","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.jpainsymman.2008.09.008","article-title":"Indwelling catheters for the management of refractory malignant ascites: a systematic literature overview and retrospective chart review.","volume":"38","author":"Fleming","year":"2009","journal-title":"J Pain Symptom Manage"},{"key":"R140-9-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1177\/104990910201900108","article-title":"Management of symptomatic ascites in recurrent ovarian cancer patients using an intra-abdominal semi-permanent catheter.","volume":"19","author":"Iyengar","year":"2002","journal-title":"Am J Hosp Palliat Care"},{"key":"R141-9-20210126","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ygyno.2005.12.043","article-title":"Long-term semi-permanent catheter use for the palliation of malignant ascites.","volume":"101","author":"Brooks","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R142-9-20210126","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.fertnstert.2005.03.087","article-title":"Innovations in fertility preservation for patients with gynecologic cancers.","volume":"84","author":"Liou","year":"2005","journal-title":"Fertil Steril"},{"key":"R143-9-20210126","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1111\/j.1525-1438.2005.00428.x","article-title":"Role of conservative surgery in ovarian cancer: the European experience.","volume":"15","author":"Colombo","year":"2005","journal-title":"Int J Gynecol Cancer"},{"key":"R144-9-20210126","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/j.ygyno.2006.08.003","article-title":"Reproduction beyond cancer: a message of hope for young women.","volume":"103","author":"Maltaris","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R145-9-20210126","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1002\/1097-0142(20011101)92:9<2412::AID-CNCR1590>3.0.CO;2-7","article-title":"Results of conservative treatment in epithelial ovarian carcinoma.","volume":"92","author":"Morice","year":"2001","journal-title":"Cancer"},{"key":"R146-9-20210126","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2008.04.040","article-title":"Outcomes of fertility-sparing surgery for invasive epithelial ovarian cancer: oncologic safety and reproductive outcomes.","volume":"110","author":"Park","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R147-9-20210126","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/gyno.2002.6805","article-title":"Outcome of reproductive age women with stage IA or IC invasive epithelial ovarian cancer treated with fertility-sparing therapy.","volume":"87","author":"Schilder","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R148-9-20210126","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S1072-7515(97)00066-5","article-title":"Conservative surgery in high-risk epithelial ovarian carcinoma.","volume":"185","author":"Raspagliesi","year":"1997","journal-title":"J Am Coll Surg"},{"key":"R149-9-20210126","first-page":"21","article-title":"Ten-year follow-up of ovarian cancer patients after second-look laparotomy with negative findings.","volume":"93","author":"Rubin","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R150-9-20210126","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/0090-8258(91)90333-Z","article-title":"Prognostic factors for recurrence following negative second-look laparotomy in ovarian cancer patients treated with platinum-based chemotherapy.","volume":"42","author":"Rubin","year":"1991","journal-title":"Gynecol Oncol"},{"key":"R151-9-20210126","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ygyno.2005.05.012","article-title":"Implications of second-look laparotomy in the context of optimally resected stage III ovarian cancer: a non-randomized comparison using an explanatory analysis: a Gynecologic Oncology Group study.","volume":"99","author":"Greer","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R152-9-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1006\/gyno.2000.6108","article-title":"Complications associated with intraperiotneal chemtoehrapy catheters.","volume":"81","author":"Makhija","year":"2001","journal-title":"Gyencol Oncol"},{"key":"R153-9-20210126","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/jso.20255","article-title":"A modified technique for insertion of intraperitoneal port for chemotherapy.","volume":"90","author":"Liou","year":"2005","journal-title":"J Surg Oncol"},{"key":"R154-9-20210126","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.ygyno.2007.12.004","article-title":"Low risk of complications associated with fenestrated peritoneal catheter used for intraperitoneal chemotherapy in advanced ovarian cancer.","volume":"109","author":"Black","year":"2008","journal-title":"Gynecol Oncol"},{"key":"R155-9-20210126","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.ygyno.2009.05.036","article-title":"Outcomes associated with different intraperitoneal chemotherapy delivery systems in advanced ovarian carcinoma: a single institutions experience.","volume":"114","author":"Ivy","year":"2009","journal-title":"Gynecol Oncol"},{"key":"R157-9-20210126","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1177\/000313480006600607","article-title":"Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin.","volume":"66","author":"Loggie","year":"2000","journal-title":"Am Surg"},{"key":"R158-9-20210126","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4251\/wjgo.v2.i2.68","article-title":"Hyperthermic intraperitoneal chemotherapy: rationale and technique.","volume":"2","author":"Gonzalez-Moreno","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"R159-9-20210126","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejso.2011.03.134","article-title":"Perioperative fast track program in intraoperative hyperthermic intraperitoneal chemotherapy (HIPEC) after cytoreductive surgery in advanced ovarian cancer.","volume":"37","author":"Cascales Campos","year":"2011","journal-title":"Eur J Surg Oncol"},{"key":"R160-9-20210126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ygyno.2011.05.004","article-title":"Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy as upfront therapy for advanced epithelial ovarian cancer: multi-institutional phase-II trial.","volume":"122","author":"Deraco","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R161-9-20210126","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ygyno.2011.04.008","article-title":"HIPEC in recurrent ovarian cancer patients: morbidity-related treatment and long-term analysis of clinical outcome.","volume":"122","author":"Fagotti","year":"2011","journal-title":"Gynecol Oncol"},{"key":"R162-9-20210126","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1002\/jso.21682","article-title":"Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer.","volume":"102","author":"Roviello","year":"2010","journal-title":"J Surg Oncol"}],"container-title":["Clinical Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00003081-201203000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,14]],"date-time":"2023-06-14T20:50:22Z","timestamp":1686775822000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003081-201203000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,3]]},"references-count":154,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/grf.0b013e31824b4629","relation":{},"ISSN":["0009-9201"],"issn-type":[{"value":"0009-9201","type":"print"}],"subject":[],"published":{"date-parts":[[2012,3]]}}}